Merck & Co., Inc.
RAHWAY, NJ · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$820.3M2026 Q3
Positions13
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.99.9%
Merck & Co., Inc. reported 13 positions worth $820.3M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: MRNA (54.2%).
10 / 13 positions shown
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | MRNA | $444.5M | 54.18% | 2,308,190 | — | — | +11.8% | |
| ▸ 2 | PSNL | $228.7M | 27.87% | 14,044,943 | — | — | -9.1% | |
| ▸ 3 | KYMR | $86.3M | 10.52% | 772,165 | — | — | +14.1% | |
| ▸ 4 | AKTS | $18.6M | 2.26% | 952,844 | — | — | -17.0% | |
| ▸ 5 | EIKN | $13.4M | 1.63% | 1,666,666 | — | — | -33.0% | |
| ▸ 6 | TRDA | $11.0M | 1.35% | 1,739,768 | — | — | -19.8% | |
| ▸ 7 | ALEC | $6.6M | 0.80% | 3,545,719 | — | — | +37.3% | |
| ▸ 8 | STRO | $4.4M | 0.54% | 272,351 | — | — | -39.0% | |
| ▸ 9 | EVAX | $4.0M | 0.48% | 1,214,126 | — | — | — | |
| ▸ 10 | VRDN | $1.9M | 0.23% | 93,414 | — | — | +49.9% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Merck & Co., Inc. hold as of Q3 2026?
Merck & Co., Inc. reported 13 positions worth $820.3M in its Q3 2026 13F filing. Largest positions: MRNA (54.2%), PSNL (27.9%), KYMR (10.5%), AKTS (2.3%) and EIKN (1.6%).
What did Merck & Co., Inc. buy in Q3 2026?
No previous quarter is available yet; the comparison appears with the next filing.
What did Merck & Co., Inc. sell in Q3 2026?
No previous quarter is available yet.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.